JNJ CFO Wolk nets 89,654-share stock sale
JOHNSON & JOHNSON Executive VP and CFO Joseph J. Wolk reported multiple equity award transactions and sales.
Rhea-AI Filing Summary
JOHNSON & JOHNSON Executive VP and CFO Joseph J. Wolk reported multiple equity award transactions and sales. He exercised stock options, performance share units, and restricted share units into common stock on February 13, 15, and 17, 2026, and received new grants of 53,793 employee stock options and 3,863 restricted share units under the company’s long‑term incentive plan.
On February 17, 2026, he sold 89,654 shares of common stock in open‑market transactions and also disposed of shares to cover tax obligations upon vesting of awards. After these transactions, direct ownership entries show 14,000 common shares, alongside indirect holdings of 68,835 shares in a spousal lifetime access trust and 2,173 shares in a 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
26 txns
Insider
Wolk Joseph J
Role
Exec VP, CFO
Sold
89,654 shs ($21.77M)
Approx. gross sale proceeds
$21.77M
Approx. exercise cost
$8.19M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Options (Right to Buy) | 19,241 | $0.00 | $0.00 |
| Exercise | Employee Stock Options (Right to Buy) | 12,066 | $0.00 | $0.00 |
| Exercise | Employee Stock Options (Right to Buy) | 33,386 | $0.00 | $0.00 |
| Exercise | Common Stock | 19,241 | $115.67 | $2.23M |
| Sale | Common Stock | 19,241 | $242.99 | $4.68M |
| Exercise | Common Stock | 12,066 | $129.51 | $1.56M |
| Sale | Common Stock | 12,066 | $242.87 | $2.93M |
| Exercise | Common Stock | 33,386 | $131.94 | $4.40M |
| Sale | Common Stock | 33,386 | $242.75 | $8.10M |
| Sale | Common Stock | 24,961 | $242.68 | $6.06M |
| Exercise | Restricted Share Units | 1,971 | $0.00 | $0.00 |
| Exercise | Restricted Share Units | 1,878 | $0.00 | $0.00 |
| Grant/Award | Employee Stock Options (Right to Buy) | 53,793 | $0.00 | $0.00 |
| Grant/Award | Restricted Share Units | 3,863 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,971 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 858 | $243.45 | $209K |
| Exercise | Common Stock | 1,878 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 817 | $243.45 | $199K |
| Exercise | Performance Share Units | 37,463 | $0.00 | $0.00 |
| Exercise | Restricted Share Units | 1,779 | $0.00 | $0.00 |
| Exercise | Common Stock | 37,463 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 15,948 | $244.55 | $3.90M |
| Exercise | Common Stock | 1,779 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 507 | $244.55 | $124K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Performance Share Units — 0 contracts (Direct);
Restricted Share Units — 9,588 contracts (Direct);
Employee Stock Options (Right to Buy) — 86,793 contracts (Direct);
Common Stock — 14,000 shares (Direct);
Common Stock — 68,835 shares (Indirect, By SLAT);
Common Stock — 2,173 shares (Indirect, By 401k)
Footnotes (16)
- F1. Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.
- F2. Shares withheld for payment of taxes upon vesting of PSUs.
- F3. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
- F4. Shares withheld for payment of taxes upon vesting of RSUs.
- F5. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.
- F6. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
- F7. This transaction was executed in multiple trades at prices ranging from $242.94 to $243.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $242.85 to $242.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $242.71 to $242.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F10. This transaction was executed in multiple trades at prices ranging from $242.59 to $242.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary.
- F12. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
- F13. Each RSU represents a contingent right to receive one share of Company Common Stock.
- F14. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
- F15. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
- F16. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did JNJ CFO Joseph Wolk report in this Form 4 filing?
Johnson & Johnson CFO Joseph J. Wolk reported exercising various equity awards into common stock, receiving new option and RSU grants, and selling shares in open‑market transactions, along with additional share dispositions to satisfy tax obligations tied to vesting of performance and restricted share units.
What new equity awards did JNJ grant to CFO Joseph Wolk?
Joseph J. Wolk was granted 53,793 employee stock options and 3,863 restricted share units on February 15, 2026, under Johnson & Johnson’s Long‑Term Incentive Plan, with the awards vesting over multi‑year schedules and each RSU representing a right to receive one common share.
Why does the JNJ Form 4 include transactions coded F for the CFO?
Transactions coded “F” represent shares withheld to pay taxes or exercise costs when awards vest or convert. For Joseph J. Wolk, several common stock dispositions with code F cover tax liabilities tied to vesting of performance share units and restricted share units under long‑term incentive awards.
What types of equity awards did JNJ CFO Joseph Wolk exercise or convert?
The filing shows Joseph J. Wolk converting performance share units, restricted share units, and employee stock options into Johnson & Johnson common stock. These transactions are reported with code “M” for exercises or conversions of derivative securities into non‑derivative common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
